Correlation Between BioNTech and 06417XAP6
Specify exactly 2 symbols:
By analyzing existing cross correlation between BioNTech SE and BNS 485 01 FEB 30, you can compare the effects of market volatilities on BioNTech and 06417XAP6 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of 06417XAP6. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and 06417XAP6.
Diversification Opportunities for BioNTech and 06417XAP6
Very good diversification
The 3 months correlation between BioNTech and 06417XAP6 is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and BNS 485 01 FEB 30 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BNS 485 01 and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with 06417XAP6. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BNS 485 01 has no effect on the direction of BioNTech i.e., BioNTech and 06417XAP6 go up and down completely randomly.
Pair Corralation between BioNTech and 06417XAP6
Given the investment horizon of 90 days BioNTech SE is expected to generate 12.38 times more return on investment than 06417XAP6. However, BioNTech is 12.38 times more volatile than BNS 485 01 FEB 30. It trades about 0.14 of its potential returns per unit of risk. BNS 485 01 FEB 30 is currently generating about -0.1 per unit of risk. If you would invest 8,800 in BioNTech SE on September 3, 2024 and sell it today you would earn a total of 3,039 from holding BioNTech SE or generate 34.53% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 98.44% |
Values | Daily Returns |
BioNTech SE vs. BNS 485 01 FEB 30
Performance |
Timeline |
BioNTech SE |
BNS 485 01 |
BioNTech and 06417XAP6 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BioNTech and 06417XAP6
The main advantage of trading using opposite BioNTech and 06417XAP6 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, 06417XAP6 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 06417XAP6 will offset losses from the drop in 06417XAP6's long position.BioNTech vs. Novavax | BioNTech vs. Ginkgo Bioworks Holdings | BioNTech vs. Crispr Therapeutics AG | BioNTech vs. Ocean Biomedical |
06417XAP6 vs. Alvotech | 06417XAP6 vs. HUTCHMED DRC | 06417XAP6 vs. Teleflex Incorporated | 06417XAP6 vs. BioNTech SE |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |